DAVID M GOLD
Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology BABYLON, NY NPI 1801897657
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology NY ABBVIE INC. All categories
General Payments — all program years on this page
$5,394.47
- Category: General Payments
- Program years: PY2018–2024
- Record count: 195
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,138.15 across 49 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,138.15 | 49 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $256.31 | 10 |
| GENZYME CORPORATION | $231.17 | 8 |
| ACADIA Pharmaceuticals Inc | $70.09 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $66.88 | 4 |
| Medtronic, Inc. | $59.26 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $57.49 | 3 |
| Supernus Pharmaceuticals, Inc. | $49.18 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $48.50 | 3 |
| Corium, Inc. | $41.94 | 3 |
| Abbott Laboratories | $40.26 | 2 |
| QOL Medical, LLC | $30.25 | 1 |
| Neurelis, Inc. | $26.54 | 1 |
| GlaxoSmithKline, LLC. | $22.41 | 1 |
| Azurity Pharmaceuticals, Inc. | $22.32 | 1 |
| Tandem Diabetes Care, Inc. | $21.41 | 1 |
| Xeris Pharmaceuticals, Inc. | $21.32 | 1 |
| Regeneron Healthcare Solutions, Inc. | $20.05 | 1 |
| Insulet Corporation | $18.66 | 1 |
| Amphastar Pharmaceuticals, Inc. | $17.93 | 1 |
| Novo Nordisk AS | $16.18 | 1 |
By program year
Records — PY2024 (49)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.